Mark Geyer is a co-founder of the Heffter Research Institute.
From the Institute website:
“Dr. Geyer is a psychopharmacologist and neuroscientist at the University of California, San Diego, where he holds the position of Professor of Psychiatry and Neurosciences and Vice-Chair for Scientific Affairs in the Department of Psychiatry. He is actively involved in both the Ph.D. Group in Neurosciences and the Clinical Psychology Ph.D. Program, and is the Director of the Neuropsychopharmacology Unit of the VA VISN 22 Mental Illness Research, Education, and Clinical Center. Since receiving his doctorate in Psychology in 1972, he has focused on basic research addressing the behavioral and neurobiological effects of psychoactive drugs. For over 25 years, he has had continuous funding from the National Institute on Drug Abuse to study the behavioral effects of hallucinogens in animals. Dr. Geyer is internationally known for his research on the psychophysiology, neurobiology, and pharmacotherapy of schizophrenia. He has published over 350 peer-reviewed papers, including many addressing the mechanisms subserving the effects of psychostimulants, hallucinogens, and entactogens. Dr. Geyer is an Associate Editor for Neuropsychopharmacology and is on the Editorial Board for additional highly ranked international journals. He is a Fellow of the American Association for the Advancement of Science and the American College of Neuropsychopharmacology and past President of the international Serotonin Club. Dr. Geyer’s broad experience as a researcher, grant reviewer, journal editor, and teacher lends invaluable scientific and professional expertise to the Institute as he provides the leadership to develop a strong program in the behavioral psychopharmacology of psychedelic agents.”